Invention Grant
- Patent Title: Respiratory syncytial virus vaccine
- Patent Title (中): 呼吸道合胞病毒疫苗
-
Application No.: US13885388Application Date: 2011-11-15
-
Publication No.: US09409973B2Publication Date: 2016-08-09
- Inventor: Xavier Saelens , Bert Schepens , Walter Fiers
- Applicant: Xavier Saelens , Bert Schepens , Walter Fiers
- Applicant Address: BE Ghent BE Ghent
- Assignee: VIB VZW,Universiteit Gent
- Current Assignee: VIB VZW,Universiteit Gent
- Current Assignee Address: BE Ghent BE Ghent
- Agency: Lathrop & Gage LLP
- Agent James H. Velema
- Priority: GB1019240.9 20101115
- International Application: PCT/EP2011/070161 WO 20111115
- International Announcement: WO2012/065997 WO 20120524
- Main IPC: A61K39/155
- IPC: A61K39/155 ; C07K16/10 ; A61K39/12 ; C12N7/02 ; C07K7/06 ; C07K14/005 ; C07K14/78 ; A61K39/385 ; A61K39/00
Abstract:
Described is a vaccine against Respiratory Syncytial Virus (RSV). More specifically, described is a recombinant subunit vaccine comprising the ectodomain of the RSV-encoded Small Hydrophobic (SH) protein. The ectodomain of SH is referred to as SHe. The ectodomain is typically presented as an oligomer, or a pentamer. Further described are antibodies, raised against the ectodomain or specific for the ectodomain, and their use for protecting a subject against RSV infection and/or for treatment of an infected subject.
Public/Granted literature
- US20130315916A1 RESPIRATORY SYNCYTIAL VIRUS VACCINE Public/Granted day:2013-11-28
Information query
